Industry: Pharmaceuticals, Biotechnology
Founded in 1991, Fermalogic is a research-driven industrial biotechnology company that develops technology to improve pharmaceutical manufacturing. We specialize in pharmaceuticals that are produced by fermentation, which encompasses a large range of products from antibiotics to anticancer agents, immunosuppressants, and many others types of natural products. We also develop technology for co-product recovery. Our first technology in this area applies to recovering isoflavones as a co-product from soy-bean based fermentations such as antibiotic fermentations. Fermalogic uses the erythromycin manufacturing process as a model system. In this area, we have developed a technology referred to as FermachannelingSM, described in the publications that are linked to this ( www.fermalogic.com )
Fermalogic Inc
2201 West Campbell Park Drive
Chicago, Illinois 60612
USA
Tel: (312) 738-0050
Fax: (312) 738-0963
Industry: Pharmaceuticals, Biotechnology
Developing biopharmaceutical products for the prevention and treatment of serious and life-threatening infections. ( www.ardeabiosciences.com )
Ardea Biosciences, Inc.
1009 Oak Hill Road Suite 201
Lafayette, California 94549
USA
Tel: (650) 845-6200
Industry: Pharmaceuticals, Biotechnology
Nyxis Neurotherapies is a privately-held, research-driven biotechnology company focused on the discovery, development and commercialization of therapeutics to treat a wide variety of neurological conditions. Nyxis Neurotherapies uses a proprietary, monoclonal antibody-derived custom peptide (MADCP) technology platform to produce highly-targeted neuro-therapeutic compounds. Headquartered in Chicago, Nyxis Neurotherapies is affiliated with both Northwestern University’s I-Tech Center and its biomedical engineering department’s Falk Center for Molecular Therapeutics. ( www.nyxis.com )
Nyxis Neurotherapies Inc
1801 Maple Ave.
Evanston, Illinois 60208
USA
Tel: (847) 491-4802
Industry: Pharmaceuticals, Biotechnology
Genopsys, Inc., is an early-phase bioengineering company with offices in Soquel, California. The company is dedicated to the development of protein pharmaceuticals using its proprietary method of directed molecular evolution. ( www.genopsys.com )
Genopsys Inc
2901 Park Ave. Suite A3
Soquel, California 95073
USA
Tel: (831) 462-4390
Fax: (831) 462-4337
Industry: Pharmaceuticals, Biotechnology
ISTN is a materials research company specializing in the development and commercialization of nanotechnology products for industrial applications in three primary focus areas: traditional products, optical electronics and biotechnology. ISTN’s Founder and President, Dr. Arthur J. Yang, has a wealth of nanotechnology-related research experience dating back to 1992, when he won an Advanced Technology Program (ATP) grant from the Department of Commerce to develop nanopore thermal insulation for Armstrong World Industries. Since its founding in 1996, ISTN has been dedicated to staying on the cutting edge of nanomaterials research. ISTN’s R&D Center is currently located in York, PA; it is also pursuing expansion plans in both the U.S. and Asia. ( www.istninc.com )
Industrial Science & Technology Network , Inc.
2101 Pennsylvania Avenue
York, Pennsylvania 17404
USA
Tel: (717) 843-0300
Fax: (717) 843-0705
Industry: Pharmaceuticals, Biotechnology
ESI also supplies several products to healthcare and to the commercial and industrial marketplaces. Applications range from cleaning surgical equipment to industrial degreasers, floor cleaners for the food industry, vehicle wash for large commercial fleets, and floor cleaners for the automotive repair industry, among several others. If it is organic and needs to be cleaned, ESI has the solution. ( www.enzymesolutions.com )
Enzyme Solutions Inc
7601 Honeywell Dr.
Fort Wayne, Indiana 46845
USA
Tel: (260) 497-0851
Industry: Pharmaceuticals, Biotechnology
Banyan Biomarkers is the leader in developing in vitro diagnostic products to address unmet clinical needs for the detection of traumatic brain injury (TBI). Currently, no simple point-of-care blood test exists for use by physicians in the emergency room or in the hospital to detect the presence and severity of brain trauma. Banyan research has identified unique and proprietary biomarkers present in the patient’s blood following injury to the brain. Detecting these biomarkers will provide early indications of brain trauma essential for earlier intervention and management. ( www.banyanbio.com )
Banyan Biomarkers Inc
PH: 386-462-6699 12085 Research Drive, Suite 109
Alachua, Florida 32615
USA
Tel: (386) 462-6699
Industry: Pharmaceuticals, Biotechnology
PURE Bioscience (PURE) develops and markets technology-based bioscience products that provide solutions to numerous global health challenges. PURE’s proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials represent innovative advances in diverse markets and lead today’s global trend toward industry and consumer use of “green” products while providing competitive advantages in efficacy and safety. PURE Bioscience, headquartered in El Cajon, California, (San Diego metropolitan area), was incorporated in 1992. ( www.purebio.com )
PURE Bioscience
1725 Gillespie Way
El Cajon, California 92020
USA
Tel: (619) 596-8600
Fax: (619) 596-8791
Industry: Pharmaceuticals, Biotechnology
National Stem Cell is also developing a platform that will allow for the growth of contaminant-free human embryonic stem (hES) cell lines which will then be made available to the research community. This new platform has the promise to become the backbone of future stem cell research. We also intend to establish the National Stem Cell Cord Blood Bank to meet the growing need for transplant grade umbilical cord blood stem cells which have been identified as a potential treatment for more than 80 diseases ranging from leukemia to sickle cell ( www.nationalstemcell.com )
National Stem Cell , Inc.
17 State Street 39Th Floor
New York, New York 10004
USA
Tel: (212) 792-6160
Industry: Pharmaceuticals, Biotechnology
At 4Cyte, we are focused on the development of novel therapeutics for metabolic disorders like diabetes and obesity, and obesity-related cancers such as breast and prostrate cancer. Our business strategy is to identify and license from leading academics premier technologies that address the key defects in these complex diseases and develop them further. Currently 4Cyte has licensed several compounds and gene targets for treating diabetes, obesity and cancer. These technologies are at various stages along the development pipeline and have the promise of being first-in-class and/or best-in-class pharmaceuticals that will revolutionize the treatment of these chronic ( www.4cyterx.com )
4Cyte Therapeutics , Inc.
800 West Baltimore St.
Baltimore, Maryland 21201
USA
Tel: (410) 531-6930